- Home
- NVS vs PM Comparison
NVS vs PM Comparison
Compare NVS & PM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVS
- PM
- Stock Information
- Founded
- NVS 1895
- PM 1987
- Country
- NVS Switzerland
- PM United States
- Employees
- NVS N/A
- PM N/A
- Industry
- NVS Biotechnology: Pharmaceutical Preparations
- PM Medicinal Chemicals and Botanical Products
- Sector
- NVS Health Care
- PM Health Care
- Exchange
- NVS Nasdaq
- PM Nasdaq
- Market Cap
- NVS 254.8B
- PM 238.8B
- IPO Year
- NVS 1991
- PM N/A
- Fundamental
- Price
- NVS $130.63
- PM $156.87
- Analyst Decision
- NVS Sell
- PM Strong Buy
- Analyst Count
- NVS 3
- PM 9
- Target Price
- NVS $118.00
- PM $190.44
- AVG Volume (30 Days)
- NVS 1.7M
- PM 5.7M
- Earning Date
- NVS 10-28-2025
- PM 10-21-2025
- Dividend Yield
- NVS 1.99%
- PM 3.76%
- EPS Growth
- NVS N/A
- PM N/A
- EPS
- NVS 7.30
- PM 5.52
- Revenue
- NVS $56,372,000,000.00
- PM $39,992,000,000.00
- Revenue This Year
- NVS $9.44
- PM $10.72
- Revenue Next Year
- NVS $2.65
- PM $7.66
- P/E Ratio
- NVS $17.88
- PM $28.34
- Revenue Growth
- NVS 12.88
- PM 7.45
- 52 Week Low
- NVS $96.06
- PM $116.12
- 52 Week High
- NVS $134.00
- PM $186.69
- Technical
- Relative Strength Index (RSI)
- NVS 56.19
- PM 54.76
- Support Level
- NVS $123.24
- PM $150.09
- Resistance Level
- NVS $133.19
- PM $158.23
- Average True Range (ATR)
- NVS 1.78
- PM 3.35
- MACD
- NVS 0.12
- PM 0.62
- Stochastic Oscillator
- NVS 67.75
- PM 87.25
About NVS Novartis AG
Novartis develops and manufactures innovative drugs. Key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States comprising close to one third of total revenue.
About PM Philip Morris International Inc
Created from the international operations of Altria in 2008, Philip Morris International sells cigarettes and reduced-risk products, including heat sticks, vapes, and oral nicotine offerings, primarily outside of the US. With the 2023 acquisition of Swedish Match, a leading manufacturer of traditional oral tobacco products and nicotine pouches primarily in the US and Scandinavia, PMI is not only dominant in smokable products but also has the Iqos and Zyn brands, which respectively dominate heated tobacco and nicotine pouches in most markets.